VIHAX Mutual Fund

NAV$49.47

Fund Essentials - as of Dec 31, 2025

Net Assets
$893M
Expense Ratio
0.16%
Dividend Yield (Current)
3.63%
Holdings
1,547
Inception Date
Mar 2, 2016
Fund Family
Vanguard (US)
Investment Style
PRO
Asset Class
PRO
Legal Structure
PRO
Dividend Frequency
Quarterly

Performance

YTD+12.64%
1 Year+25.86%
3 Year+20.58%
5 Year+12.43%
10 Year+10.58%

Asset Allocation

Stocks: 97.87%
Bonds: 0.27%
Cash: 1.47%
Other: 0.39%

Price Chart (6M)

View Full Chart →

Top Holdings

View All →
TickerNameWeight
ROG:SMRoche Holding Ag1.72%
SANB11:BVBanco Santander Brasil Sa/braz1.64%
HSBA:LNHsbc Securities Inc1.61%
NOVN:SMNovartis Ag1.57%
NESN:SMNestle Sa1.49%
Top 10 Concentration: 14.21%Report Date: Dec 31, 2025
Download all 1547 holdings for VIHAX
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Dividend Yield (Current)
3.63%
Frequency
Quarterly
Latest Distribution
$0.47
-

Peer Comparison

Benchmark
PRO
Peer outperformance: PRO
Category rank: PRO
This Mutual Fund
PRO
Peer Avg
PRO
See how VIHAX ranks against its peers
Category rank, peer-average returns and outperformance, updated daily.
$49$29/mo
Claim the $29 launch price
First 500 subscribers, then $49/mo. Cancel anytime. From MarketXLS, trusted since 2014.

VIHAX Mutual Fund Overview

VIHAX Mutual Fund (Vanguard International High Dividend Yield Index Fund Admiral Shares) is managed by Vanguard (US) with $892.7M in net assets. VIHAX expense ratio is 0.16%, holding 1547 positions across sectors including Unknown, Financials, Energy. Inception date: 2016-03-02.

VIHAX performance shows a YTD return of 12.64%. The 1-year return is 25.86% and the 5-year return is 12.43%. VIHAX dividend yield stands at 3.63%, paid quarterly.

VIHAX top holdings include Roche Holding Ag (1.7%), Banco Santander Brasil Sa/braz (1.6%), Hsbc Securities Inc (1.6%), Novartis Ag (1.6%), Nestle Sa (1.5%). View all VIHAX holdings, sector breakdown, or dividend history.

VIHAX can be compared against other funds using the overlap calculator or side-by-side comparison tool. VIHAX alternatives are available via the screener, along with tax-loss harvesting opportunities.